Dotmatics Platform Selected by Leading Brazilian Medicinal Chemistry Team to Boost Research Activities

BISHOPS STORTFORD, England–(BUSINESS WIRE)–Dotmatics announced today that after careful consideration, the Medicinal Chemistry Team from the University of São Paulo (USP), Brazil has selected the Dotmatics Platform (including Browser, Studies Notebook and Vortex) as their data management system. The team based at the School of Pharmaceutical Sciences of Ribeirão Preto (Dept. of Pharmaceutical Sciences), University of São Paulo is led by Dr. Flavio da Silva Emery, a South American authority on the medicinal chemistry of natural products.

“Medicinal chemistry is a fast moving area. We are focused on rapidly advancing our research whilst following all of the correct legal requirements to conform to Brazilian and worldwide pharmaceutical standards.  After exhaustive evaluation, we concluded that the Dotmatics Platform will fulfill our current and future requirements,” said Dr. da Silva Emery.  “We are positive that we will save considerable time and money by avoiding the repetition of experiments.”

The Dotmatics Platform will enable Dr. da Silva Emery’s group to keep a detailed register of the natural compounds harvested from several Brazilian Biomes as well as the novel compounds synthesized in Ribeirão Preto. The deployment of Studies Notebook (ELN) will facilitate the recording of research results and ease the continuity of research projects across generations of students and researchers. The system’s main benefits include the ability to search through experiment results going back several years as well as revealing multiple data types in a single view i.e. chemistry, biology, documents, etc.. This data can then be used to perform complex analysis and pick leads that can be further developed into novel drugs.

“Dr. da Silva Emery is spearheading a revolution in data management in Brazil. Our aim is to provide the platform to enable scientists to extract the maximum information from their chemistry and biology data.  Using Dotmatics solutions, Dr. da Silva Emery will obtain the very best from such groundbreaking research whilst preserving the integrity of the data,” said Dr. Mariana Vaschetto, VP Marketing at Dotmatics.  “We are delighted to welcome such a great team to our family of users and are looking forward to a successful collaboration for years to come.”

About Dotmatics:

At the forefront of innovation, Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile pharmaceutical, biotechnology, chemical industries and academia. Dotmatics’ enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organizations, from discovery research to development to early manufacturing.  The web-based knowledge solutions dramatically improve the way scientific data is queried, managed and shared within and across organizations. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, screening data management, SAR analysis, reporting, and visualization. A privately owned company, Dotmatics was founded in 2005 and is headquartered in the UK.